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Abstract
The rostral interstitial nucleus of the medial longitudinal fascicle (riMLF) contains premotor neurons essential for the
generation of rapid vertical eye movements. The Alzheimer’s disease (AD)-related cytoskeletal changes and -amyloid deposits in
this nucleus were examined in 30 autopsy cases and compared to the involvement of three associated nuclei — Edinger–Westphal
nucleus, nucleus of Darkschewitsch and interstitial nucleus of Cajal. The riMLF displays slight cytoskeletal alterations already in
the early stages in the development of the cortical cytoskeletal pathology (cortical NFT/NT-stages I–II, representing the
preclinical phase of AD). In the cortical NFT/NT-stages III–IV (i.e. incipient phase of AD), the cytoskeletal pathology in the
riMLF is pronounced and in stages V–VI (i.e. clinical phase of AD) it is severe. The progression of the cytoskeletal pathology
in the riMLF correlates significantly with the cortical NFT/NT-stages I–VI that reflect the clinical course of AD. Isolated
-amyloid deposits appear in the riMLF for the first time in the final -amyloid stage. In the Edinger–Westphal nucleus, in the
nucleus of Darkschewitsch and most markedly in the interstitial nucleus of Cajal, the pathological changes were significantly less
severe than those in the riMLF. In the event that the cytoskeletal pathology impairs the function of the premotor neurons of the
riMLF, one would predict a progressive slowing of vertical saccades corresponding to the advancing cortical NFT/NT-stages.
© 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Vertical saccades are triggered by high frequency
discharges on the part of premotor burst neurons,
shown by experimental and clinical studies to reside in
the rostral interstitial nucleus of the medial longitudinal
fascicle (riMLF) (Bu¨ttner-Ennever, Bu¨ttner, Cohen, &
Baumgartner, 1982; Leigh & Zee, 1991, 1992; Horn,
Bu¨ttner-Ennever, Suzuki, & Henn, 1995; Horn & Bu¨t-
tner-Ennever, 1998; Horn, Bu¨ttner, & Bu¨ttner-Ennever,
1999). The premotor burst neurons of the riMLF re-
ceive afferents from the ventral layers of the superior
colliculus and project to the motoneuron pools of the
oculomotor and trochlear nuclei that innervate the
vertical-pulling eye muscles (Figs. 1 and 2a). The slow-
ing of the vertical saccades usually indicates a malfunc-
tion in burst cells of the riMLF. Likewise, the
neighboring interstitial nucleus of Cajal (iC) contributes
to vertical saccades (Figs. 1 and 2b), but is more
involved in the integration of eye-velocity into eye-posi-
tion signals (Leigh & Zee, 1991, 1992; Horn et al., 1995,
1999; Horn & Bu¨ttner-Ennever, 1998).
Severe impairments of memory, disorientation with
regard to time and place, impaired judgment, lexical
dysfunctions, apraxia, agnosia, and changes in person-
ality and behavior are among the most striking clinical
symptoms of Alzheimer’s disease (AD) (Schofield &
Mayeux, 1998), whereas overt neurological deficits of
vertical saccades have been detected only occasionally
in patients suffering from AD (Daffner, Scinto,
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Fig. 1. Simplified block diagram including the components engaged in
vertical saccadic performance together with their known anatomical
interconnections (iC, interstitial nucleus of Cajal; riMLF, rostral
interstitial nucleus of the medial longitudinal fascicle; III, oculomotor
nucleus; IV, trochlear nucleus).
tin, Crain, Sisodia, & Troncoso, 1998) and, initially,
they appear as a non-argyrophilic material in the
perikarya and dendrites of affected neurons (Goedert,
1993; Braak et al., 1994; Kosik & Greenberg, 1994;
Goedert, Jakes, & Vanmechelen, 1995; Price et al.,
1998). The gradual amassing of this material leads to
the formation of the solid and, in time, argyrophilic
neurofibrillary material appear as neurofibrillary tan-
gles (NFTs) in perikarya and as neuropil threads (NTs)
in dendrites (Gallyas, 1971; Braak & Braak, 1991a;
Goedert, 1993; Braak et al., 1994; Price et al., 1998).
The extracellular deposits consist of insoluble fibrils
containing the protein -amyloid and occur in a wide
array of plaque types within the neuropil as well as in
the walls of cerebral blood vessels (Probst et al., 1991;
Price et al., 1998; Thal, Ru¨b, Schultz, Sassin, Ghe-
bremedhin, Del Tredici, Braak, & Braak, 2000).
The present study aims at drawing the attention of
vision researchers and clinicians to the progressive in-
volvement of the riMLF during the development of the
AD-related cytoskeletal pathology.
2. Materials and methods
The brains of 30 individuals (16 females, mean age
81.56.7 years; 14 males, mean age 78.99.1 years)
obtained at autopsy were classified according to a
staging procedure permitting differentiation between six
stages in the development of the AD-related neurofibril-
lary pathology within the cerebral cortex (cortical
NFT/NT-stages I–VI) and between three stages in the
intracerebral evolution of -amyloid deposition (-amy-
loid stages A–C) (Braak & Braak, 1991b, 1997a) (Table
Weintraub, Guinenessy, & Mesulam, 1992). Accord-
ingly, it was with some surprise that our brain material
showed evidence of significant damage to the nerve cells
of the riMLF in the form of AD-related cytoskeletal
pathology.
The pathological changes that gradually develop in
the course of AD are based on intraneuronal and
extraneuronal deposits of abnormal proteins. The intra-
neuronal deposits originate subsequent to the abnormal
phosphorylation of the cytoskeletal protein  (Probst,
Langui, & Ulrich, 1991; Goedert, 1993; Braak, Braak,
& Mandelkow, 1994; Price, Thinakaran, Borchelt, Mar-
Fig. 2. Schematized frontal sections cut perpendicular to the intercommissural axis of Forel showing the rostral midbrain together with the
posterior regions of the thalamus. (a) Rostral midbrain with the rostral interstitial nucleus of the medial longitudinal fascicle (riMLF). (b) Rostral
midbrain with the interstitial nucleus of Cajal (iC), the nucleus of Darkschewitsch (nD) and the Edinger–Westphal nucleus (EW). (CG, central
gray; CM, centromedian nucleus of the thalamic central complex; EW, Edinger–Westphal nucleus; iC, interstitial nucleus of Cajal; MD,
mediodorsal nuclei of the thalamus; nD, nucleus of Darkschewitsch; PF, parafascicular nucleus of the thalamic central complex; PP,
peripeduncular nucleus; PU, pulvinar; PV, paraventricular nuclei of the thalamus; R, red nucleus; riMLF, rostral interstitial nucleus of the medial
longitudinal fascicle; SN, substantia nigra; SPF, subparafascicular nucleus of the thalamic central complex; tr, tractus retroflexus; V, third
ventricle; VPM, ventral posterior medial nucleus of the thalamus; VPMpc, ventral posterior medial nucleus of the thalamus, parvocellular part;
III, oculomotor nucleus).
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Table 1
Case number (C), age (A), gender (G) and neuropathological classification of the cases examined. All cases were classified according to an
established staging system to the severity and distribution of the AD-related cortical neurofibrillary pathology (N: cortical NFT/NT-stages I-VI),
as well as intracerebral -amyloid deposits (AM: -amyloid stages A-C) (Braak & Braak, 1991b; Braak & Braak, 1997a)a
GC NA AM riMLF EW nD iC
NF AT8 A NF AT8 A NF AT8 A NF AT8 A
m I 0 0 1 0 01 157 0 0 0 0 0 0 0
732 f I 0 0 1 0 0 1 0 0 0 0 0 0 0
m I 0 0 1 0 0 177 03 0 0 0 0 0 0
m I 0 0 1 0 0 24 079 0 0 0 0 0 0
f I 0 0 1 0 0 180 05 0 0 0 0 0 0
m II 0 0 1 0 0 16 073 0 0 0 0 0 0
f II 0 0 1 0 0 175 07 0 0 0 0 0 0
778 m II 0 0 1 0 0 1 0 0 0 0 0 0 0
809 m II 0 0 1 0 0 1 0 0 0 0 0 0 0
m II 0 0 1 0 0 188 010 0 0 0 0 0 0
6511 m III B 0 2 0 1 2 0 0 1 0 0 0 0
f III B 0 2 0 0 176 012 0 1 0 0 0 0
f III B 0 n.d. 0 0 n.d.13 079 0 n.d. 0 0 n.d. 0
m III B 0 n.d. 0 1 n.d.79 014 0 n.d. 0 0 n.d. 0
m III 0 0 2 0 0 1 0 0 1 015 083 0 0
m III B 1 1 0 1 184 016 0 1 0 0 0 0
7817 f IV C 1 2 2 1 2 0 0 1 1 0 1 0
7818 f IV C 1 2 1 1 1 0 1 2 1 0 0 0
f IV B 1 2 0 1 188 019 0 1 0 0 0 0
9020 f IV 0 1 2 0 1 1 0 1 2 0 0 0 0
f IV C 1 n.d. 1 2 n.d.90 121 0 n.d. 1 0 n.d. 0
f V C 1 2 1 1 222 180 1 2 1 1 1 0
f V C 2 3 1 1 285 123 1 2 1 0 1 0
f V C 2 3 1 2 2 1 1 2 124 186 1 0
f V C 1 3 1 2 286 125 1 2 1 0 1 0
8626 m V C 2 3 1 1 2 0 1 2 1 1 1 0
8927 m V C 2 3 1 1 2 0 1 2 1 1 1 0
f VI C 2 3 1 2 269 028 1 2 1 1 1 0
m VI C29 288 n.d. 1 1 n.d. 1 1 n.d. 1 1 n.d. 0
f VI C 2 n.d. 1 2 n.d. 0 1 n.d. 1 1 n.d. 09130
a The columns 6-8 supply the severity (0=no lesions; 1=mild: 1–5 lesions; 2=marked: 6–25 lesions; 3=severe: more than 25 lesions;
n.d.=not determined) of the neurofibrillary pathology (NF), AT8-immunopositive cytoskeletal pathology (AT8), and -amyloidosis (A) in the
rostral interstitial nucleus of the medial longitudinal fascicle (riMLF). For comparative purposes, the severity of the respective changes in the
Edinger-Westphal nucleus (EW) is shown in columns 9–11, that of the nucleus of Darkschewitsch (nD) in columns 12-14, and that of the
interstitial nucleus of Cajal (iC) in columns 15–17.
1). All of the brains were fixed by immersion in a 4%
aqueous solution of formaldehyde. Thereafter, they
were dehydrated, embedded in polyethylene glycol
(PEG 1000, Merck) and cut into an uninterrupted series
of 100-m frontal sections (Smithson, MacVicar, &
Hatton, 1983; Braak & Braak, 1991b).
A serial collection consisting of the 1st, 11th, 21st etc.
equidistant sections stained both for Nissl material
(Darrow red) and lipofuscin pigmentation (aldehyde-
fuchsin) (Braak, 1980; Braak & Braak, 1991b) served as
a means of topographical orientation. A serial collec-
tion of the 2nd, 12th, 22nd etc. equidistant sections was
then stained with a modified silver-iodide Gallyas tech-
nique for detection of AD-related neurofibrillary
changes (Gallyas, 1971; Braak & Braak, 1991a),
whereas the 3rd serial collection underwent staining
with the modified Campbell–Switzer silver-pyridine
method to highlight the AD-related -amyloid deposits
(Campbell, Switzer, & Martin, 1987; Braak & Braak,
1991a). In 25 cases, a 4th serial collection was used to
assess reactions between the abnormally phosphory-
lated  protein and the monoclonal antibody AT8,
which does not cross-react with normal  epitopes
(Innogenetics, Ghent, Belgium) (Mercken, Vander-
meeren, Lu¨bke, Six, Boons, Van de Voorde, Martin, &
Gheuens, 1992; Braak et al., 1994; Goedert et al., 1995).
The free-floating sections were incubated for 40 h at
4°C (antibody dilution 1:2000). Following processing
with the second biotinylated antibody (anti-mouse IgG,
2 h), immunoreactions were visualized by means of the
ABC complex (Vectastain) and 3,3-diaminobenzidine-
tetra-HCl/H2O2 (DAB, D5637 Sigma). In 15 of the
cases (two cases at cortical NFT/NT-stages I–V and
five cases at stage V), a further collection of sections
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was immunostained, as described above with the excep-
tion of a higher dilution of the AT8 antibody (1:3000).
This last set of sections was counterstained for lipofus-
cin deposits and Nissl material to confirm the location
of the immunopositive material. All of the sections were
cleared and mounted in a synthetic resin (Permount
Fisher).
In addition to an average of three equidistant sec-
tions through the riMLF treated with the silver-iodide
Gallyas technique or by the modified Campbell–
Switzer silver-pyridine method, an average of three
equidistant sections through the riMLF processed with
the antibody AT8 were examined per case. The severity
of the AD-related alterations was assessed by counting
the number of AT8-immunopositive perikarya, NFT/
NTs and -amyloid deposits per section using the fol-
lowing scale: no lesions=0; one to five lesions
(mild)=1; six to 25 lesions (marked)=2; more than 25
lesions (severe)=3. Counting was performed at a final
magnification of 10:1 and blind to the results of the
classification of the AD-related cortical pathology. In
each of the cases, the severity of the abnormal alter-
ations in the riMLF was compared to the extent of the
pathological changes in adjacent nuclei: Edinger–West-
phal, nucleus of Darkschewitsch, interstitial nucleus of
Cajal.
The one-way analysis of variance, according to
Kruskal and Wallis (H-test), was used to determine the
degree to which the nuclei-specific AD-related cy-
toskeletal pathology is dependent upon the stages I–VI.
Our working hypothesis that the severity of the pathol-
ogy in the four nuclei gradually increases with the
increasing severity of cortical neurofibrillary pathology
was tested by means of a non-parametric trend analysis.
The correlation between the severity of the pathology
seen in Gallyas silver stained sections and that seen in
immunoreactions was described using Kendall’s rank
correlation coefficient tau () (Bortz, Lienert, &
Boehnke, 1990).
3. Results
3.1. Anatomical remarks
The rostral interstitial nucleus of the medial longitu-
dinal fascicle nucleus (riMLF) is situated dorsomedial
to the red nucleus and ventral to the thalamus (Fig. 2a).
Dorsally, it is bordered by the thalamo-subthalamic
paramedian artery (Bu¨ttner-Ennever et al., 1982; Leigh
& Zee, 1991; Horn & Bu¨ttner-Ennever, 1998; Horn et
al., 1999). In frontal sections, the riMLF appears as a
wing-shaped nucleus in close proximity to the medially
situated central gray and to the dorsally located sub-
parafascicular nucleus of the thalamic central complex
(Fig. 2a) (Bu¨ttner-Ennever et al., 1982; Horn & Bu¨t-
tner-Ennever, 1998; Horn et al., 1999). The nerve cells
of the riMLF are loosely scattered among the fiber
bundles of the rostral portions of the medial longitudi-
nal fascicle (MLF).
The tractus retroflexus separates the riMLF from the
caudally located interstitial nucleus of Cajal (iC), which
likewise lies within the MLF and is situated laterally to
the Edinger–Westphal nucleus (Fig. 2b) (Bu¨ttner-En-
never et al., 1982; Olszewski & Baxter, 1982; Horn &
Bu¨ttner-Ennever, 1998; Horn et al., 1999). The iC is
bordered dorsally by the nucleus of Darkschewitsch
(nD), which forms an indentation on the ventral border
of the central gray (Fig. 2b) (Bu¨ttner-Ennever et al.,
1982; Olszewski & Baxter, 1982; Leigh & Zee, 1991;
Horn & Bu¨ttner-Ennever, 1998; Horn et al., 1999). The
Edinger–Westphal nucleus (EW) is located medially to
the iC (Fig. 2b) and abuts ventrally on the rostral
oculomotor nucleus (Olszewski & Baxter, 1982; Leigh
& Zee, 1991).
3.2. The AD-related cytoskeletal pathology in the
riMLF and associated nuclei
The development of the AD-related immunoreactive
cytoskeletal changes in the riMLF is already detectable
when NFT/NT-stage I pathology is found in the cere-
bral cortex and is linearly linked to the progress of the
NFT/NT-stages I–VI within the cortex (Tables 1 and
2). The sections immunostained with the antibody AT8
and counterstained for lipofuscin deposits and Nissl
material reveal that the large, elongated and pre-
sumably premotor neurons oriented with their long
axes parallel to the mediolateral axis of the riMLF
(Horn & Bu¨ttner-Ennever, 1998) are the preferential
targets of these changes (Fig. 3a).
At cortical stages I–II, alongside several thin AT8-
immunoreactive dendrites, a few AT8-immunopositive
somata occur in the medial portions of the riMLF
(Table 1; Fig. 3a). In cases at NFT/NT-stages III–IV,
the riMLF shows numerous immunoreactive dendrites
and nerve cell somata located predominantly in the
medial aspects of the riMLF (Fig. 3b). In stages V–VI,
the AT8-immunoreactive cytoskeletal pathology in the
riMLF is at its peak (Table 1), with numerous im-
munopositive perikarya surrounded by a weave of short
or long immunoreactive dendrites (Fig. 3(c) and Fig.
4a).
The AD-related NFT/NTs in the riMLF occur with
regularity for the first time at the cortical NFT/NT-
stage IV (Table 1). The severity of the neurofibrillary
changes in the riMLF at stages IV–VI is routinely less
than that of the AT8-immunopositive cytoskeletal
pathology observable there (Table 1). Nevertheless, it
increases linearly with the growing severity of the im-
munoreactive lesions and this in correlation with con-
current cortical NFT/NT-stages I–VI (Table 2).
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As in the riMLF, the severity of the AT8-im-
munopositive cytoskeletal pathology in the EW, nD
and iC corresponds to that of the cortical NFT/NT-
stages I–VI (Tables 1 and 2). In addition, in all three
nuclei, the increasing gravity of the AT8-immunoreac-
tive lesions correlates with that of the AD-related neu-
rofibrillary changes and, again, is linked linearly to the
progression of stages I–VI (Table 2).
The EW, like the riMLF, consistently exhibits AT8-
immunopositive neurons up to NFT/NT-stages I–II
(Table 1) and routinely shows the first neurofibrillary
changes at stage IV (Table 1). At stages IV–VI, how-
ever, the EW is less severely involved in the AT8-im-
munoreactive cytoskeletal pathology than the riMLF
(Table 1; Fig. 4b). Furthermore, in the majority of
cases at cortical NFT/NT-stages V–VI, fewer NFT/
NTs are encountered in the EW than in the riMLF
(Table 1).
The first AT8-immunopositive cytoskeletal alter-
ations appear with regularity in the nD at cortical
NFT/NT stage III and neurofibrillary tangles occur
Fig. 3. AD-related AT8-immunopositive cytoskeletal changes in the
rostral interstitial nucleus of the medial longitudinal fascicle (riMLF)
(AT8-immunostaining, 100 m PEG sections). Arrows mark large
and elongated AT8-immunoreactive nerve cells in the riMLF. The
asterisk in (c) points to the topographically useful thalamo-subthala-
mic paramedian artery. For topographical orientation, see Fig. 2(a)
(CG, central gray; R, red nucleus). Initial degree of AT8-immunore-
active (a) cytoskeletal pathology in the riMLF in cortical NFT/NT-
stage I (case 2, Table 1). Moderate AT8-immunoreactive (b)
cytoskeletal alterations in riMLF of a representative case at cortical
NFT/NT-stage III (case 11, Table 1). Severe AT8-immunoreactive (c)
cytoskeletal changes are seen in the riMLF in cases at the cortical
NFT/NT-stage V (case 27, Table 1).
Table 2
Correlation between the AD-related cytoskeletal pathology in the
nuclei investigated and the severity of the cortical neurofibrillary
pathology together with the correlation between the severity of the
AT8-immunopositive cytoskeletal pathology and the severity of the
AD-related neurofibrillary pathology in the nuclei studieda
riMLF EW nD IC
27.01 14.80AT 8: H corr 22.82 20.70
P 0.0005 0.025 0.0005 0.001
17.04 4.18 8.91 5.80AT 8: H lin
0.025P 0.050.0005 0.005
21.8024.0022.38NFT/NT: H corr 26.17
0.0010.0005P 0.00050.0005
NFT/NT: H lin 8.3712.0515.9118.02
0.0010.0005 0.0050.0005P
0.73AT8–NFT/NT:  0.80 0.64 0.84
0.005 0.010 0.005 0.005P
a riMLF, rostral interstitial nucleus of the medial longitudinal
fascicle; EW, Edinger–Westphal nucleus; nD, nucleus of Darksche-
witsch; iC, interstitial nucleus of Cajal): line 1, value of the test
statistic H corr of the one-way analysis of variance for the AT8-im-
munopositive nerve cell somata and nerve cell processes; line 2,
significance level of the value of the test statistic H corr of line 1; line
3, value of the test statistic H lin from the trend analyses for the
AT8-immunopositive nerve cell somata and nerve cell processes; line
4, significance level of the value of the test statistic H lin of line 3; line
5, value of the test statistic H corr of the one-way analysis of variance
for the NFT/NT; line 6 - significance level of the value of the test
statistic H corr of line 5; line 7, value of the test statistic H lin from
the trend analyses for the NFT/NT; line 8, signifcance level of the
value of the test statistic H lin of line 7; line 9, value of Kendalls rank
correlation tau between the severity of the AT8-immunopositive
cytsoskeletal pathology and the severity of the AD-related neurofi-
brillary pathology; line 10, significance level of the test statistic 
according to Kendall.
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there consistently up to stage V (Table 1). In cases at
stages V–VI, the nD displays a marked, but less devel-
oped immunoreactive cytoskeletal pathology than the
riMLF (Table 1; Fig. 4c). Moreover, the nD of most of
the cases at stages V–VI exhibits a lower number of
NFT/NTs when compared with the riMLF (Table 1).
In the final two cortical NFT/NT-stages V–VI, some
isolated AT8-immunoreactive neurons are routinely
demonstrable in the iC as well (Table 1; Fig. 4c).
AD-related NFT/NTs, however, occur in this nucleus
only inconstantly at these stages (Table 1).
3.3. Deposits of -amyloid in the riMLF and
associated nuclei
Some isolated AD-related -amyloid deposits consis-
tently develop in the riMLF and the nD in the final
stage of -amyloidosis (stage C) (Table 1). The lesions
present as relatively small, irregularly outlined, dark
plaque-like deposits. Even in stage C, there are very few
-amyloid deposits in the iC and EW (Table 1).
4. Discussion
The riMLF is regularly a target of both the AD-re-
lated cytoskeletal pathology and -amyloidosis, al-
though the alterations there appear ‘prima vista’
somewhat unimpressive. In view of the riMLF’s low
nerve cell density, however, and compared with the
extent of the lesions in the EW, nD and iC, the
cytoskeletal pathology in the riMLF is remarkably
severe.
An earlier study conducted on the rostral midbrain
entailing thin sections of brain tissue and conventional
staining techniques failed to detect the involvement of
the riMLF in AD (Hunter, 1985). The fact that we
managed to demonstrate for the first time the existence
of the AD-related cytoskeletal pathology in the riMLF
underscores the advantage of immunocytochemical or
advanced silver staining methods when it comes to
identifying the location of the less prominent AD-re-
lated lesions, particularly when such methods are ap-
plied to relatively thick tissue sections. The superiority
of thick tissue sections over paraffin sections results
from the optical superposition of biological structures
(Braak & Braak, 1991a; Heinsen & Heinsen, 1991).
The AD-related changes appear preferentially in the
large-sized and elongated nerve cells of the riMLF that
are involved in the generation of vertical saccades
(Horn & Bu¨ttner-Ennever, 1998; Horn et al., 1999). The
cytoskeletal alterations in these neurons presumably
exert a detrimental influence on their function, thereby
drawing attention to themselves via a reduction of the
maximal velocity of vertical saccades. Conceivably, the
severity of the pathology in the riMLF suffices to cause
Fig. 4. AD-related AT8-immunopositive cytoskeletal changes in the
rostral midbrain in cases at cortical NFT/NT-stage V (AT8-im-
munostaining, counterstaining with aldehydefuchsin-Darrow red, 100
m PEG sections). Arrows indicate AT8-immunopositive nerve cell
somata. For topographical orientation see Fig. 2(a,b) (CG, central
gray; EW, Edinger–Westphal nucleus; iC, interstitial nucleus of
Cajal; nD, nucleus of Darkschewitsch; riMLF, rostral interstitial
nucleus of the medial longitudinal fascicle; III, oculomotor nucleus).
(a) Severe AT8-immunopositive cytoskeletal pathology in the rostral
interstitial nucleus of the medial longitudinal fascicle (riMLF) at
cortical NFT/NT-stage V (case 26, Table 1). (b) Marked AT8-im-
munoreactive cytoskeletal lesions occur in the Edinger–Westphal
nucleus (EW) in cases at the cortical NFT/NT-stage V (case 22, Table
1). (c) Pronounced AT8-immunopositive cytoskeletal alterations in
the nucleus of Darkschewitsch (nD) and slight lesions in the intersti-
tial nucleus of Cajal (iC) at cortical NFT/NT-stage (case 26, Table 1).
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a slowing of vertical saccades, whereby a certain
threshold is required before disorders of these rapid eye
movements can be detected without the aid of electro-
physiological devices.
According to some sources, slowing of vertical (pre-
dominantly upward) saccades is regarded as a phe-
nomenon of normal aging (Hotson & Steinke, 1988).
Ongoing post-mortem studies of so-called ‘normally’
aging individuals between 60 and 80 years of age can
assign 70% of the cases to cortical NFT/NT-stages I–II
(i.e. preclinical phase of AD) and 20% to cortical
NFT/NT-stages III–IV (i.e. incipient phase of AD)
(Braak & Braak, 1991b, 1997a,b; Schofield & Mayeux,
1998). Given the fact that at cortical NFT/NT stages
I–IV the riMLF is consistently involved in the AD-re-
lated cytoskeletal pathology, it remains to be seen
whether the abnormal changes in this nucleus account
for the slowing of vertical saccades associated with
normal aging, as demonstrated in some oculographic
studies (Hotson & Steinke, 1988).
By way of its protectal afferents and its projections to
the nerve cells of the ciliary ganglion, the cholinergic
neurons of the EW adjust the width of the pupil
(Bu¨ttner-Ennever, Cohen, Horn, & Reisine, 1996). Sev-
eral studies have demonstrated that persons suffering
from AD exhibit a hypersensitive pupillary response to
the cholinergic antagonist tropicamide (Scinto, Daffner,
Dressler, Ransil, Rentz, Weintraub, Mesulam, & Pot-
ter, 1994; Gomez-Tortoza, del Barrio, & Jimenez-Al-
faro, 1996; Kurz, Marquand, Fremke, & Leipert, 1997).
Similar to Hunter, Scinto et al. observed cytoskeletal
alterations in the EW of individuals clinically diagnosed
as having AD and explained this hypersensitivity pupil-
lary response by means of the lesions in the EW
(Hunter, 1985; Scinto, Wu, Firla, Daffner, Saroff, &
Geula, 1999). Inasmuch as Scinto et al. found these
alterations in the EW of three clinically silent cases that
showed AD-related cortical cytoskeletal changes as well
(Scinto et al., 1999), they speculated that the involve-
ment of the EW might be an early event in the evolu-
tion of the AD-related cytoskeletal pathology. Our
study performed on staged brain material confirms
their conjecture that the EW is among the early targets
of the cytoskeletal changes.
There is an acknowledged need for clinical signs
capable of serving as early diagnostic markers for AD
and, at the same time, as parameters for monitoring the
clinical progression as well as effects of therapy
(Almkvist & Winblad, 1999). Since the EW appeared to
become involved early on in the course of AD, Scinto
et al. hypothesized that a hypersensitive pupillary re-
sponse could function as an early marker for the dis-
ease process (Scinto et al., 1999). Although the EW,
similar to riMLF, is affected by the AD-associated
cytoskeletal pathology already in the cortical NFT/NT-
stages I–II (the preclinical phase), the degree of the EW
involvement at cortical NFT/NT-stages III–IV (the
incipient phase) is less severe than the degree of pathol-
ogy in the riMLF. Thus, we have reached the conclu-
sion that future clinical studies devoted to improving
the diagnosis of AD should re-double their efforts in
assessing vertical saccadic performance.
In closing, the progression of the cytoskeletal pathol-
ogy in the riMLF correlates closely with the cortical
NFT/NT-stages I–VI, thereby reflecting the clinical
course of AD (Bancher, Braak, Fischer, & Jellinger,
1993; Braak & Braak, 1991b, 1997a,b). Against the
background of this correlation, the following trajectory
emerges: a progressive slowing of vertical saccades oc-
curs, which extends from the preclinical phase beyond
the incipient phase well into the clinical end-stages of
AD. In view of the pressing need for improved diagnos-
tic parameters and given the developmental pattern of
the AD-related cytoskeletal changes observable in the
riMLF, additional oculographic studies are called for
to verify our hypothesis here that clinical evaluation of
vertical saccades could be implemented one day as an
index both (1) for identifying AD patients while they
are still in the preclinical or incipient phases of the
disorder and, eventually, (2) for monitoring the course
of the disease and ongoing patient response to drug
regimens.
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